GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sesen Bio Inc (STU:PCBK) » Definitions » Shiller PE Ratio

Sesen Bio (STU:PCBK) Shiller PE Ratio : (As of May. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sesen Bio Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sesen Bio Shiller PE Ratio Historical Data

The historical data trend for Sesen Bio's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sesen Bio Shiller PE Ratio Chart

Sesen Bio Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sesen Bio Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sesen Bio's Shiller PE Ratio

For the Biotechnology subindustry, Sesen Bio's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sesen Bio's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sesen Bio's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sesen Bio's Shiller PE Ratio falls into.



Sesen Bio Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sesen Bio's E10 for the quarter that ended in Dec. 2022 is calculated as:

For example, Sesen Bio's adjusted earnings per share data for the three months ended in Dec. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=-0.755/125.2218*125.2218
=-0.755

Current CPI (Dec. 2022) = 125.2218.

Sesen Bio Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201303 -11.581 98.209 -14.766
201306 -8.080 98.518 -10.270
201309 -8.266 98.790 -10.478
201312 -0.294 98.326 -0.374
201403 -11.568 99.695 -14.530
201406 -7.507 100.560 -9.348
201409 -10.243 100.428 -12.772
201412 -7.948 99.070 -10.046
201503 -6.653 99.621 -8.363
201506 -6.415 100.684 -7.978
201509 -8.910 100.392 -11.114
201512 -9.731 99.792 -12.211
201603 -7.004 100.470 -8.729
201606 -5.874 101.688 -7.233
201609 16.216 101.861 19.935
201612 -2.844 101.863 -3.496
201703 -4.675 102.862 -5.691
201706 -5.340 103.349 -6.470
201709 -6.209 104.136 -7.466
201712 -3.380 104.011 -4.069
201803 -1.784 105.290 -2.122
201806 -2.739 106.317 -3.226
201809 -3.085 106.507 -3.627
201812 -1.231 105.998 -1.454
201903 -1.416 107.251 -1.653
201906 -11.859 108.070 -13.741
201909 -2.361 108.329 -2.729
201912 -5.940 108.420 -6.861
202003 5.611 108.902 6.452
202006 -4.262 108.767 -4.907
202009 -3.226 109.815 -3.679
202012 -1.973 109.897 -2.248
202103 -5.880 111.754 -6.589
202106 -2.490 114.631 -2.720
202109 6.120 115.734 6.622
202112 0.852 117.630 0.907
202203 -0.073 121.301 -0.075
202206 -3.027 125.017 -3.032
202209 2.020 125.227 2.020
202212 -0.755 125.222 -0.755

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sesen Bio  (STU:PCBK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sesen Bio Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sesen Bio's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sesen Bio (STU:PCBK) Business Description

Traded in Other Exchanges
N/A
Address
245 First Street, Suite 1800, Cambridge, MA, USA, 02142
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.

Sesen Bio (STU:PCBK) Headlines

From GuruFocus

Pacific Continental Corp. (PCBK) President/COO Roger S Busse buys 1,000 Shares

By GuruFocus Research GuruFocus Editor 10-15-2009

Pacific Continental Corp. (PCBK) CFO Michael Reynolds sells 1,650 Shares

By GuruFocus Research GuruFocus Editor 02-22-2010

Pacific Continental Corp. (PCBK) CEO Hal Brown buys 5,000 Shares

By GuruFocus Research GuruFocus Editor 10-15-2009